GSK-25
GSK-25 is a selective kinase inhibitor with IC50 values of 398 nM for RSK1 and 1000 nM for p70S6K, demonstrating good selectivity over a panel of 31 kinases and minimal cytochrome P450 inhibition (>2.2 μM) . It is a valuable research tool for studying RSK signaling pathways in cancer and metabolic disease models, both in vitro and in vivo.
Product Specifications
CAS Number
874119-56-9
Product Name Alternative
Inhibitor, GSK 25, GSK25, GSK-25, inhibit, mTOR (p70S6K), orally, p70S6K, blood, bioavailable, pressure, P450, selective, Ribosomal S6 Kinase (RSK), Rho-associated kinase, Rho-associated protein kinase, Rho-kinase, S6K, S6 Kinase, S6Kinase, ROCK, ROK, RSK1
Field of Research
Cell Biology, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.59% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.9 mM) ; DMSO:60 mg/mL (116.88 mM)
Smiles
CC1=C (C (N=C (N1) c1ccnc (Cl) c1) c1ccc (Cl) cc1F) C (=O) Nc1cc2cn[nH]c2cc1F
Molecular Formula
C24H16Cl2F2N6O
Molecular Weight
513.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1115315 Inquire
Recombinant Mycobacterium tuberculosis DNA-directed RNA polymerase subunit beta (rpoB), partial
Sign In for Pricing
View Details 237498-01 10 mg
E-N-Carboxy[2H2]methyl-L-Lysine discontinued. See 269951
Sign In for Pricing
View Details 237498-02 50 mg
E-N-Carboxy[2H2]methyl-L-Lysine discontinued. See 269951
Sign In for Pricing
View Details